Antisense oligonucleotide GTI-2040
Term · Oncology and biomedicine · MLC-T-ONC-011085
A 20-mer antisense oligonucleotide complementary to a coding region in the mRNA of the R2 small subunit component of human ribonucleotide reductase. GTI-2040 decreases mRNA and protein levels of R2 in vitro and may inhibit tumor cell proliferation in human tumors in vivo.
| Identifier | MLC-T-ONC-011085 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011085",
"term": "Antisense oligonucleotide GTI-2040",
"field": "Oncology and biomedicine",
"definition": "A 20-mer antisense oligonucleotide complementary to a coding region in the mRNA of the R2 small subunit component of human ribonucleotide reductase. GTI-2040 decreases mRNA and protein levels of R2 in vitro and may inhibit tumor cell proliferation in human tumors in vivo.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/antisense-oligonucleotide-gti-2040/"
}
Record 2,224 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.